ANALYSIS OF THE APPLICATION OF FOREIGN QUALITY MANAGEMENT EXPERIENCE IN PHARMACEUTICAL ENTERPRISES OF UKRAINE
DOI:
https://doi.org/10.32782/2226-2008-2024-5-16Keywords:
pharmaceutical products, quality, GMP standards, GxP system, TQMAbstract
The paper presents an analysis of the integration of foreign quality management practices within international pharmaceutical enterprises, emphasizing the significance of international standards such as GMP, EMA guidelines, and the principles of Kaizen and TQM. The study explores how these global frameworks can enhance production quality, safety, and compliance in Ukrainian pharmaceutical sector. By comparing quality management systems from the USA, the EU, and Japan, the research identifies key best practices for improving operational efficiency, quality consistency, and regulatory alignment in Ukraine. The study aims to analyze the foreign experience of quality management at pharmaceutical enterprises of the USA, the EU, Japan, and other developed countries in order to determine the best practices and the possibilities of their integration into the Ukrainian standards of the pharmaceutical industry. Materials and methods. The study includes an analysis of the activities of 13 pharmaceutical enterprises (3 each from the USA, the EU, and 4 from Japan), as well as 3 Ukrainian companies that have already integrate certain elements of foreign quality management experience. In order to achieve the goal of the research, the following methods were used: analysis of normative documents; comparative analysis; case study. Results. The integration of global quality management practices can significantly improve product quality at Ukrainian pharmaceutical enterprises, strengthening their position on the international market. The implementation of such approaches requires investments in the modernization of production facilities, training of personnel and improvement of internal procedures, but in the long term these measures will provide Ukrainian pharmaceutical enterprises with a higher level of product quality, production efficiency and reputation in the global market.
References
Lebedynets’ VO, Kovalenko SM. Designing of process model of quality management systems of pharmaceutical enterprise. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. 2010; 6 (14): 28–35. (In Ukrainian). Available from: http://nbuv.gov.ua/UJRN/Uezyaf_2010_6_6.
Lebedinets VA, Kovalenko SN, Takhtaulova NA. Implementation of the deming-shewhart cycle (pdca) for regulating quality management system processes of pharmaceutical companies. Upravlinnia, ekonomika ta zabezpechennia yakosti v farmatsii. 2012; 1(21): 11–17. (In Ukrainian). Available from: http://nbuv.gov.ua/UJRN/Uezyaf_2012_1_4.
Medushevskiy S. Automated Information Systems as Elements of the Pharmaceutical Enterprise Quality Management System. Technical Sciences and Technologies. 2020; 4 (22): 65–71. Available from: https://doi.org/10.25140/2411-5363-2020-4(22)-65-71%20.
Bohuslavs’kyy YeP, Voskoboynikova HL, Hoy AM. Innovatsiynyy rozvytok ta udoskonalennya upravlinnya yakistyu suchasnoho farmatsevtychnoho pidpryyemstva. Zbirnyk materialiv XIV naukovo-praktychnoyi konferentsiyi “QUALITY MANAGEMENT IN PHARMACY”. Kharkiv, 22.05.2020; 19. Available from: https://quality.nuph.edu.ua/wp-content/uploads/2020/06/@Збірник-матеріалів-конференції-УЯФ-2020.pdf.
Haluzevi standarty seriyi GxP (GLP/GCP/GMP). System Management Certification. Available from: https://sm-mt.com.ua/services/standartu-serii-gxp-glp-gcp-gmp/.
Good Manufacturing Practices. WHO. Available from: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards/gmp.
A Guide on Quality Risk Management (QRM). 2024. Available from: https://safetyculture.com/topics/quality-riskmanagement/.
EU guide to good manufacturing practice for medicinal products. Available from: https://www.gmp-compliance.org/files/guidemgr/Part%20I%20EU_GMP_GUIDE.pdf.
Quality guidelines. Regulatory and procedural guidance. European Medicines Agency. 2021. Available from: https://www.ema.europa.eu/en/human-regulatory-overview/research-and-development/scientific-guidelines/quality-guidelines.
Singh J, Singh H. Kaizen philosophy: a review of literature. The Icfai University Journal of Operations Management. 2009; VIII (2): 51–72. Available from: https://www.iupindia.in/509/IJOM_Kaizen_Philosophy_51.html.
Belous-Sergeeva S. System integration of total quality management (TQM) in pharmaceutical companies. Theoretical and Practical Aspects of Economics and Intellectual Property. 2018; 17: 182–187. https://doi.org/10.31498/2225-6407.17.2018.160007.
Oleksiychuk O. Yakist’ ye nevid’yemnoyu chastynoyu polityky «Farmak». 2018. Available from: https://farmak.ua/leader_opinion/farmak-zavzhdi-rozglyadav-usyu-svoyu-diyalnist-cherez-prizmu-yakosti-tse-stalo-odniyeyu-z-golovnihskladovih-uspihu-kompaniyi/.
Zvit pro upravlinnya kompaniyi «Arterium» za 2020. Available from: https://griml.com/QzR1g.
Vyrobnytstvo. Biofarma. Available from: https://biopharma.ua/virobnictvo.